Fair Accountability and Innovative Research Drug Pricing Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (May 9, 2019)
Fair Accountability and Innovative Research Drug Pricing Act of 2019
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.
What just happenedMay 9, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
- Introduced in SenateMay 9, 2019
- May 9, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - May 9, 2019IntroReferral10000
Introduced in Senate